Literature DB >> 18374478

Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin.

B Buchinger1, S Spitzer, H Karlic, K Klaushofer, F Varga.   

Abstract

It is well known that suramin influences proliferation and differentiation of tumour cells. To study whether and how suramin effects osteosarcoma (OS) cells, proliferation, differentiation, LOX mRNA expression and telomerase activity (TA) was analysed in the human MG-63 and U-2 OS, and the rat UMR-106 OS cell lines. Data show that suramin inhibited proliferation in the human cell lines and upregulated alkaline phosphatase activity. TA was attenuated in the human cells while in UMR-106 it was not changed. In UMR-106 suramin had no influence on osteocalcin and LOX expression, in the human cells however, both genes were upregulated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374478     DOI: 10.1016/j.canlet.2008.02.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling.

Authors:  Jianxue Li; Xuesong Gu; Yinghua Ma; Monica L Calicchio; Dong Kong; Yang D Teng; Lili Yu; Andrew M Crain; Timothy K Vartanian; Renata Pasqualini; Wadih Arap; Towia A Libermann; Evan Y Snyder; Richard L Sidman
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

Review 2.  Lysyl Oxidase: Its Diversity in Health and Diseases.

Authors:  Suchitra Kumari; Tarun Kumar Panda; Tapaswini Pradhan
Journal:  Indian J Clin Biochem       Date:  2016-05-11

Review 3.  Lysyl oxidase: a potential target for cancer therapy.

Authors:  V M Berlin Grace; C Guruvayoorappan
Journal:  Inflammopharmacology       Date:  2010-11-24       Impact factor: 4.473

4.  A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells.

Authors:  Sahra Borges; Heike R Döppler; Peter Storz
Journal:  Breast Cancer Res Treat       Date:  2014-02-08       Impact factor: 4.872

5.  Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models.

Authors:  Friedrich Schütze; Florian Röhrig; Sandra Vorlová; Sabine Gätzner; Anja Kuhn; Süleyman Ergün; Erik Henke
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

6.  Lysyl oxidase polymorphisms and susceptibility to osteosarcoma.

Authors:  Yang Liu; Bitao Lv; Zhimin He; Yujia Zhou; Carrie Han; Guodong Shi; Rui Gao; Ce Wang; Lili Yang; Haihan Song; Wen Yuan
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.